BiGEN made an agreement with ProJect Pharmaceutics (PJP), a private biotech located in Germany, to promote PJP’s formulation service for biopharmaceutical products such as mAb, recombinant protein, ADC/cytotoxic medicine, and virus. Through this agreement, BiGEN obtained an exclusive right to promote PJP’s formulation service in the territory of Asia.